PHVS
insider transactionsPharvaris N.V. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-241.5K
0 buy · 241.5K sell
Net value · 90d
-$7.2M
$0 in · $7.2M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
36
0 buy · 241.5K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Berndt Modig KEY
Chief Executive Officer · 10b5-1
$3.1K
100 sh · $31.46
Own -0%
-
Sell·S
Berndt Modig KEY
Chief Executive Officer · 10b5-1
$68.0K
2.2K sh · $31.05
Own -2%
-
Other·F
Chief Medical Officer
$3.8K
117 sh · $32.20
Own -0%
-
Other·F
Chief Medical Officer
$3.4K
109 sh · $31.51
Own -0%
-
Sell·S
Principal Accounting Officer
$82.4K
2.7K sh · $30.87
Own -5%
-
Exercise·M
Principal Accounting Officer
$0
5.5K sh
Own +32%
-
Sell·S
Principal Accounting Officer
$169.1K
5.5K sh · $30.74
Own -10%
-
Exercise·M
Principal Accounting Officer
$110.0K
5.5K sh · $20.00
Own +11%
-
Exercise·M
Principal Accounting Officer
$0
1.8K sh
Own +7%
-
Sell·S
Principal Accounting Officer
$56.0K
1.8K sh · $30.60
Own -4%
-
Exercise·M
Principal Accounting Officer
$36.6K
1.8K sh · $20.00
Own +4%
-
Sell·S
David W. Nassif KEY
CFO / CLO
$303.1K
10.0K sh · $30.31
Own -8%
-
Sell·S
Director
$292.9K
9.7K sh · $30.29
Own -64%
-
Exercise·M
Director · 10b5-1
$0
10.0K sh
Own +1000%
-
Sell·S
Director · 10b5-1
$293.2K
10.0K sh · $29.32
Own -40%
-
Exercise·M
Director · 10b5-1
$80.5K
10.0K sh · $8.05
Own +66%
-
Sell·S
Berndt Modig KEY
Chief Executive Officer · 10b5-1
$67.0K
2.3K sh · $29.22
Own -2%
-
Sell·S
Chief Commercial Officer · 10b5-1
$299.2K
10.0K sh · $29.92
Own -18%
-
Exercise·M
Director
$0
5.3K sh
Own +160%
-
Sell·S
Director
$139.2K
4.7K sh · $29.82
Own -31%
-
Sell·S
Director
$159.1K
5.3K sh · $29.83
Own -26%
-
Exercise·M
Director
$119.0K
5.3K sh · $22.31
Own +35%
-
Sell·S
Chief Technical Ops Officer
$260.9K
8.7K sh · $29.82
Own -20%
-
Other·F
Chief Medical Officer
$3.5K
117 sh · $29.95
Own -0%
-
Other·F
Chief Medical Officer
$3.3K
109 sh · $30.09
Own -0%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
143 sh
Own +0%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
14.0K sh
Own +7%
-
Sell·S
Chief Medical Officer · 10b5-1
$4.4K
143 sh · $31.00
Own -0%
-
Sell·S
Chief Medical Officer · 10b5-1
$423.0K
14.0K sh · $30.16
Own -17%
-
Exercise·M
Chief Medical Officer · 10b5-1
$36.7K
14.2K sh · $2.59
Own +21%
-
Sell·S
Johannes Gerardus Christiaan Petrus Schikan
Director · 10b5-1
$20.8K
670 sh · $31.03
Own -0%
-
Sell·S
Johannes Gerardus Christiaan Petrus Schikan
Director · 10b5-1
$860.6K
28.4K sh · $30.30
Own -7%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
15.0K sh
Own +7%
-
Sell·S
Chief Medical Officer · 10b5-1
$453.6K
15.0K sh · $30.24
Own -18%
-
Exercise·M
Chief Medical Officer · 10b5-1
$38.9K
15.0K sh · $2.59
Own +23%
-
Exercise·M
Chief Early Development · 10b5-1
$0
18.0K sh
Own +28%
-
Exercise·M
Chief Early Development · 10b5-1
$0
3.7K sh
Own +69%
-
Sell·S
Chief Early Development · 10b5-1
$580.9K
19.2K sh · $30.26
Own -13%
-
Sell·S
Chief Early Development · 10b5-1
$544.6K
18.0K sh · $30.26
Own -24%
-
Exercise·M
Chief Early Development · 10b5-1
$144.9K
18.0K sh · $8.05
Own +32%
-
Sell·S
Chief Early Development · 10b5-1
$111.9K
3.7K sh · $30.26
Own -6%
-
Exercise·M
Chief Early Development · 10b5-1
$9.6K
3.7K sh · $2.59
Own +7%
-
Sell·S
Johannes Gerardus Christiaan Petrus Schikan
Director · 10b5-1
$115.2K
3.8K sh · $30.07
Own -1%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
3.7K sh
Own +2%
-
Sell·S
Chief Medical Officer · 10b5-1
$112.2K
3.7K sh · $30.06
Own -6%
-
Exercise·M
Chief Medical Officer · 10b5-1
$9.7K
3.7K sh · $2.59
Own +6%
-
Exercise·M
Chief Early Development · 10b5-1
$0
3.7K sh
Own +41%
-
Sell·S
Chief Early Development · 10b5-1
$111.2K
3.7K sh · $30.06
Own -2%
-
Sell·S
Chief Early Development · 10b5-1
$111.3K
3.7K sh · $30.08
Own -6%
-
Exercise·M
Chief Early Development · 10b5-1
$9.6K
3.7K sh · $2.59
Own +7%
-
Sell·S
Johannes Gerardus Christiaan Petrus Schikan
Director · 10b5-1
$3.0K
100 sh · $30.03
Own -0%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
100 sh
Own +0%
-
Sell·S
Chief Medical Officer · 10b5-1
$3.0K
100 sh · $30.03
Own -0%
-
Exercise·M
Chief Medical Officer · 10b5-1
$259
100 sh · $2.59
Own +0%
-
Exercise·M
Chief Early Development · 10b5-1
$0
100 sh
Own +1%
-
Exercise·M
Chief Early Development · 10b5-1
$259
100 sh · $2.59
Own +0%
-
Sell·S
Chief Early Development · 10b5-1
$3.0K
100 sh · $30.03
Own -0%
-
Sell·S
Johannes Gerardus Christiaan Petrus Schikan
Director · 10b5-1
$210.4K
7.0K sh · $30.05
Own -2%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
7.0K sh
Own +7%
-
Sell·S
Chief Medical Officer · 10b5-1
$210.4K
7.0K sh · $30.05
Own -10%
-
Exercise·M
Chief Medical Officer · 10b5-1
$18.1K
7.0K sh · $2.59
Own +11%
-
Exercise·M
Chief Early Development · 10b5-1
$0
7.0K sh
Own +7%
-
Exercise·M
Chief Early Development · 10b5-1
$0
500 sh
Own +3%
-
Sell·S
Chief Early Development · 10b5-1
$210.4K
7.0K sh · $30.05
Own -4%
-
Sell·S
Chief Early Development · 10b5-1
$210.4K
7.0K sh · $30.05
Own -11%
-
Exercise·M
Chief Early Development · 10b5-1
$56.4K
7.0K sh · $8.05
Own +12%
-
Sell·S
Chief Early Development · 10b5-1
$15.0K
500 sh · $30.00
Own -1%
-
Exercise·M
Chief Early Development · 10b5-1
$1.3K
500 sh · $2.59
Own +1%
-
Sell·S
Berndt Modig KEY
Chief Executive Officer · 10b5-1
$65.6K
2.3K sh · $28.60
Own -2%
-
Other·F
Chief Medical Officer
$6.5K
226 sh · $28.78
Own -0%
-
Other·F
Principal Accounting Officer
$14.6K
548 sh · $26.63
Own -1%
-
Sell·S
Berndt Modig KEY
Chief Executive Officer · 10b5-1
$5.7K
200 sh · $28.42
Own -0%
-
Sell·S
Berndt Modig KEY
Chief Executive Officer · 10b5-1
$641.6K
23.1K sh · $27.74
Own -14%
-
Other·F
Principal Accounting Officer
$33.3K
1.2K sh · $28.56
Own -2%
-
Other·F
Principal Accounting Officer
$32.9K
1.2K sh · $28.25
Own -2%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Berndt Modig KEY 10b5-1 | Sell S | 100 | $3.1K |
| Jun 15, 2026 | Berndt Modig KEY 10b5-1 | Sell S | 2.2K | $68.0K |
| Jun 12, 2026 | Peng Lu | Other F | 117 | $3.8K |
| Jun 11, 2026 | Peng Lu | Other F | 109 | $3.4K |
| Jun 4, 2026 | Anna Nijdam | Sell S | 2.7K | $82.4K |
| May 22, 2026 | Anna Nijdam | Exercise M | 5.5K | $0 |
| May 22, 2026 | Anna Nijdam | Sell S | 5.5K | $169.1K |
| May 22, 2026 | Anna Nijdam | Exercise M | 5.5K | $110.0K |
| May 21, 2026 | Anna Nijdam | Exercise M | 1.8K | $0 |
| May 21, 2026 | Anna Nijdam | Sell S | 1.8K | $56.0K |
| May 21, 2026 | Anna Nijdam | Exercise M | 1.8K | $36.6K |
| May 21, 2026 | David W. Nassif KEY | Sell S | 10.0K | $303.1K |
| May 21, 2026 | Viviane Monges | Sell S | 9.7K | $292.9K |
| May 20, 2026 | Elisabeth Bjork 10b5-1 | Exercise M | 10.0K | $0 |
| May 20, 2026 | Elisabeth Bjork 10b5-1 | Sell S | 10.0K | $293.2K |
| May 20, 2026 | Elisabeth Bjork 10b5-1 | Exercise M | 10.0K | $80.5K |
| May 18, 2026 | Berndt Modig KEY 10b5-1 | Sell S | 2.3K | $67.0K |
| May 15, 2026 | Wim Souverijns 10b5-1 | Sell S | 10.0K | $299.2K |
| May 15, 2026 | Robert Glassman | Exercise M | 5.3K | $0 |
| May 15, 2026 | Robert Glassman | Sell S | 4.7K | $139.2K |
| May 15, 2026 | Robert Glassman | Sell S | 5.3K | $159.1K |
| May 15, 2026 | Robert Glassman | Exercise M | 5.3K | $119.0K |
| May 15, 2026 | Stefan Andreas Abele | Sell S | 8.7K | $260.9K |
| May 12, 2026 | Peng Lu | Other F | 117 | $3.5K |
| May 11, 2026 | Peng Lu | Other F | 109 | $3.3K |
| May 1, 2026 | Peng Lu 10b5-1 | Exercise M | 143 | $0 |
| May 1, 2026 | Peng Lu 10b5-1 | Exercise M | 14.0K | $0 |
| May 1, 2026 | Peng Lu 10b5-1 | Sell S | 143 | $4.4K |
| May 1, 2026 | Peng Lu 10b5-1 | Sell S | 14.0K | $423.0K |
| May 1, 2026 | Peng Lu 10b5-1 | Exercise M | 14.2K | $36.7K |
| Apr 30, 2026 | Johannes Gerardus Christiaan Petrus Schikan 10b5-1 | Sell S | 670 | $20.8K |
| Apr 30, 2026 | Johannes Gerardus Christiaan Petrus Schikan 10b5-1 | Sell S | 28.4K | $860.6K |
| Apr 30, 2026 | Peng Lu 10b5-1 | Exercise M | 15.0K | $0 |
| Apr 30, 2026 | Peng Lu 10b5-1 | Sell S | 15.0K | $453.6K |
| Apr 30, 2026 | Peng Lu 10b5-1 | Exercise M | 15.0K | $38.9K |
| Apr 30, 2026 | Anne Lesage 10b5-1 | Exercise M | 18.0K | $0 |
| Apr 30, 2026 | Anne Lesage 10b5-1 | Exercise M | 3.7K | $0 |
| Apr 30, 2026 | Anne Lesage 10b5-1 | Sell S | 19.2K | $580.9K |
| Apr 30, 2026 | Anne Lesage 10b5-1 | Sell S | 18.0K | $544.6K |
| Apr 30, 2026 | Anne Lesage 10b5-1 | Exercise M | 18.0K | $144.9K |
| Apr 30, 2026 | Anne Lesage 10b5-1 | Sell S | 3.7K | $111.9K |
| Apr 30, 2026 | Anne Lesage 10b5-1 | Exercise M | 3.7K | $9.6K |
| Apr 29, 2026 | Johannes Gerardus Christiaan Petrus Schikan 10b5-1 | Sell S | 3.8K | $115.2K |
| Apr 29, 2026 | Peng Lu 10b5-1 | Exercise M | 3.7K | $0 |
| Apr 29, 2026 | Peng Lu 10b5-1 | Sell S | 3.7K | $112.2K |
| Apr 29, 2026 | Peng Lu 10b5-1 | Exercise M | 3.7K | $9.7K |
| Apr 29, 2026 | Anne Lesage 10b5-1 | Exercise M | 3.7K | $0 |
| Apr 29, 2026 | Anne Lesage 10b5-1 | Sell S | 3.7K | $111.2K |
| Apr 29, 2026 | Anne Lesage 10b5-1 | Sell S | 3.7K | $111.3K |
| Apr 29, 2026 | Anne Lesage 10b5-1 | Exercise M | 3.7K | $9.6K |
| Apr 23, 2026 | Johannes Gerardus Christiaan Petrus Schikan 10b5-1 | Sell S | 100 | $3.0K |
| Apr 23, 2026 | Peng Lu 10b5-1 | Exercise M | 100 | $0 |
| Apr 23, 2026 | Peng Lu 10b5-1 | Sell S | 100 | $3.0K |
| Apr 23, 2026 | Peng Lu 10b5-1 | Exercise M | 100 | $259 |
| Apr 23, 2026 | Anne Lesage 10b5-1 | Exercise M | 100 | $0 |
| Apr 23, 2026 | Anne Lesage 10b5-1 | Exercise M | 100 | $259 |
| Apr 23, 2026 | Anne Lesage 10b5-1 | Sell S | 100 | $3.0K |
| Apr 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan 10b5-1 | Sell S | 7.0K | $210.4K |
| Apr 22, 2026 | Peng Lu 10b5-1 | Exercise M | 7.0K | $0 |
| Apr 22, 2026 | Peng Lu 10b5-1 | Sell S | 7.0K | $210.4K |
| Apr 22, 2026 | Peng Lu 10b5-1 | Exercise M | 7.0K | $18.1K |
| Apr 22, 2026 | Anne Lesage 10b5-1 | Exercise M | 7.0K | $0 |
| Apr 22, 2026 | Anne Lesage 10b5-1 | Exercise M | 500 | $0 |
| Apr 22, 2026 | Anne Lesage 10b5-1 | Sell S | 7.0K | $210.4K |
| Apr 22, 2026 | Anne Lesage 10b5-1 | Sell S | 7.0K | $210.4K |
| Apr 22, 2026 | Anne Lesage 10b5-1 | Exercise M | 7.0K | $56.4K |
| Apr 22, 2026 | Anne Lesage 10b5-1 | Sell S | 500 | $15.0K |
| Apr 22, 2026 | Anne Lesage 10b5-1 | Exercise M | 500 | $1.3K |
| Apr 16, 2026 | Berndt Modig KEY 10b5-1 | Sell S | 2.3K | $65.6K |
| Apr 16, 2026 | Peng Lu | Other F | 226 | $6.5K |
| Apr 11, 2026 | Anna Nijdam | Other F | 548 | $14.6K |
| Apr 9, 2026 | Berndt Modig KEY 10b5-1 | Sell S | 200 | $5.7K |
| Apr 9, 2026 | Berndt Modig KEY 10b5-1 | Sell S | 23.1K | $641.6K |
| Apr 6, 2026 | Anna Nijdam | Other F | 1.2K | $33.3K |
| Apr 1, 2026 | Anna Nijdam | Other F | 1.2K | $32.9K |
About PHVS insider trading
This page tracks insider transactions for Pharvaris N.V. (PHVS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.